These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36199759)

  • 1. Prevalence of Chronic Obstructive Pulmonary Disease in an Urban Area. Changes in COPD Ten Years on.
    García Castillo E; Alonso Pérez T; Peláez A; Pérez González P; Soriano JB; Ancochea J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2431-2441. PubMed ID: 36199759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain -A Summary of the EPISCAN II Protocol.
    Alfageme I; de Lucas P; Ancochea J; Miravitlles M; Soler-Cataluña JJ; García-Río F; Casanova C; Rodríguez González-Moro JM; Cosío BG; Sánchez G; Soriano JB
    Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):38-47. PubMed ID: 30612602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
    García Castillo E; Alonso Pérez T; Peláez A; Pérez González P; Miravitlles M; Alfageme I; Casanova C; Cosío BG; de Lucas P; García-Río F; Rodríguez González-Moro JM; Soler-Cataluña JJ; Sánchez G; Soriano JB; Ancochea J
    Arch Bronconeumol; 2023 Mar; 59(3):142-151. PubMed ID: 36549937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Determinants of COPD in Spain: EPISCAN II.
    Soriano JB; Alfageme I; Miravitlles M; de Lucas P; Soler-Cataluña JJ; García-Río F; Casanova C; Rodríguez González-Moro JM; Cosío BG; Sánchez G; Ancochea J
    Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):61-69. PubMed ID: 32950310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco.
    Al Wachami N; Arraji M; Iderdar Y; Mourajid Y; Boumendil K; Bouchachi FZ; Jaouhar S; Guennouni M; Laamiri F; Elkhoudri N; Bandadi L; Louerdi ML; Hilali A; Chahboune M
    Int J Chron Obstruct Pulmon Dis; 2024; 19():375-387. PubMed ID: 38343493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study.
    Rey-Brandariz J; Pérez-Ríos M; Ahluwalia JS; Beheshtian K; Fernández-Villar A; Represas-Represas C; Piñeiro M; Alfageme I; Ancochea J; Soriano JB; Casanova C; Cosío BG; García-Río F; Miravitlles M; de Lucas P; Rodríguez González-Moro JM; Soler-Cataluña JJ; Ruano-Ravina A
    Arch Bronconeumol; 2023 Nov; 59(11):717-724. PubMed ID: 37500327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions.
    Ancochea J; Miravitlles M; García-Río F; Muñoz L; Sánchez G; Sobradillo V; Duran-Tauleria E; Soriano JB
    Arch Bronconeumol; 2013 Jun; 49(6):223-9. PubMed ID: 23317767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: Findings from a Community-based Household Survey.
    Adhikari TB; Acharya P; Högman M; Neupane D; Karki A; Drews A; Cooper BG; Sigsgaard T; Kallestrup P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2319-2331. PubMed ID: 33061350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
    Ghattas C; Dai A; Gemmel DJ; Awad MH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study.
    Zachariades AG; Zachariadou T; Adamide T; Anagnostopoulou U; Georgiou A; Gourgoulianis KI
    COPD; 2012 Jun; 9(3):259-67. PubMed ID: 22432899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru.
    Jaganath D; Miranda JJ; Gilman RH; Wise RA; Diette GB; Miele CH; Bernabe-Ortiz A; Checkley W;
    Respir Res; 2015 Mar; 16(1):40. PubMed ID: 25889777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of COPD and tobacco smoking in Malopolska region--results from the BOLD study in Poland.
    Nizankowska-Mogilnicka E; Mejza F; Buist AS; Vollmer WM; Skucha W; Harat R; Pajak A; Gasowski J; Frey J; Nastalek P; Twardowska M; Janicka J; Szczeklik A
    Pol Arch Med Wewn; 2007 Sep; 117(9):402-10. PubMed ID: 18062562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Obstructive Pulmonary Disease Prevalence and Associated Risk Factors in Adults Aged 40 Years and Older in Southeast China: A Cross-Sectional Study During 2019-2020.
    Chen J; Yin Y; Zhang Y; Lin X; Chen T; Yang Z; Wang D; Zhong W
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2317-2328. PubMed ID: 36159656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.
    Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P
    Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.